OMF - Madison Paskell, 16, Type B-cell acute lymphoblastic leukemia, East Bridgewater with Dr. Andrew Place, Associate Director of Developmental Therapeutics, Pediatric Hematologic Malignancy Program, Dana-Farber 8-21-18
In March, Madison had repetitive sinus and ear infections and long-term abdominal pain. Her pediatrician decided to conduct blood work and found abnormal results. Further tests and procedures confirmed that Madison had leukemia.
Her treatment has consisted of many different rounds of chemotherapy, steroids, bone marrow biopsies, and lumbar punctures.
Madison's family includes her mother, Julie, 38, father, Chris, 39, and sister, Kennedy, 6.
Madison is a rising junior at East Bridgewater Junior Senior High School. In her spare time, she loves hanging out with her friends and family.
Her favorite part of the Jimmy Fund Clinic is hanging out with the nurses. She also loves Dr. Place for his sense of humor throughout her treatment.
Dr. Place specializes in the treatment of childhood leukemia and lymphoma. Dr. Place is also a clinical investigator studying novel targeted therapies in relapsed acute leukemia.
He is a nationally recognized clinical trialist in pediatric oncology and serves on leadership committees of several large consortia including the Dana-Farber Cancer Institute ALL Consortium, the Therapeutic Advances in Childhood Leukemia Consortium and the Children’s Oncology Group.
Dr. Place is also the Chief Medical Officer of the Institutional Centers for Clinical and Translational Research at Boston Children’s Hospital.
Dr. Place earned his MD and PhD degrees at Dartmouth College prior to completing his Pediatric Residency and Pediatric Hematology/Oncology fellowship at Boston Children’s Hospital and the Dana-Farber Cancer Institute. Dr. Place joined the Pediatric Hematology/Oncology faculty in 2012.